Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets
Biomolecules · 20.03.2026 · 16 (3) · 470
DOI: 10.3390/biom16030470 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 20.03.2026. Verfasst von Umberto Capece und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro Malattie Endocrine e Metaboliche, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS and Uni…. Hauptthemen laut MEDLINE: Oxidative Stress, Diabetic Cardiomyopathies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a distinct myocardial disorder that develops independently of coronary artery disease and hypertension and represents a major contributor to heart failure in patients with diabetes. Beyond hemodynamic alterations, DCM is driven by complex molecular mechanisms involving metabolic dysregulation, mitochondrial dysfunction, inflammation, and fibrotic remodeling. Increasing evidence identifies oxidative stress as a central integrative process linking these pathogenic pathways in the diabetic heart. Chronic hyperglycemia, insulin resistance, and altered substrate utilization promote excessive generation of reactive oxygen species, overwhelming endogenous antioxidant defenses and disrupting myocardial redox homeostasis. Oxidative stress induces direct damage to lipids, proteins, and DNA while simultaneously activating redox-sensitive signaling pathways that amplify inflammation, endothelial dysfunction, cardiomyocyte apoptosis, and fibrosis. In addition, epicardial and visceral adipose tissue have emerged as active contributors to myocardial oxidative stress through paracrine and systemic mechanisms, reinforcing inflammatory and fibrotic crosstalk. This review provides a comprehensive overview of the molecular sources and targets of oxidative damage in DCM, examines the impairment of antioxidant defense systems, and discusses emerging therapeutic strategies aimed at restoring redox balance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Malattie Endocrine e Metaboliche, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS and Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- Meditrial Europe, 00198 Roma, Italy.
- Diagnostic and Therapeutic Medicine Department, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
- Department of Medical, Surgical and Pharmacology, University of Sassari, 07100 Sassari, Italy.
- Division of Cardiology, Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
ORCID-Profile: Davide Nilo, Roberto Nilo, Vincenzo Russo, Marco Alfonso Perrone, Carlo Acierno, Ferdinando Carlo Sasso, Alfredo Caturano
Zitieren
APA
Capece, U., Nilo, D., Morciano, C., Nilo, R., Spiezia, S., Sircana, M. C., Russo, V., Perrone, M. A., Bonfrate, L., Acierno, C., Sasso, F. C., & Caturano, A. (2026). Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets. Biomolecules, 16(3), 470. https://doi.org/10.3390/biom16030470
Vancouver
Capece U, Nilo D, Morciano C, Nilo R, Spiezia S, Sircana MC, et al. Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets. Biomolecules. 2026;16(3):470. doi:10.3390/biom16030470
BibTeX
@article{Capece2026,
author = {Capece, Umberto and Nilo, Davide and Morciano, Cassandra and Nilo, Roberto and Spiezia, Serenella and Sircana, Marta Chiara and Russo, Vincenzo and Perrone, Marco Alfonso and Bonfrate, Leonilde and Acierno, Carlo and Sasso, Ferdinando Carlo and Caturano, Alfredo},
title = {Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {470},
doi = {10.3390/biom16030470}
}
EUVIMED